OurInsightsTitle

Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

Case health economic

Development of the first HTA-ready cost-effectiveness model for epidermolysis bullosa (EB)

Register to access the Tolley insights